Financhill
Back

Insmed 10K Form

Sell
41

INSM
Insmed

Last Price:
$67.76
Seasonality Move:
7.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive INSM News And Ratings

See the #1 stock for the next 7 days that we like better than INSM

INSM Financial Statistics

Sales & Book Value

Annual Sales: $363.7M
Cash Flow: $-272.2M
Price / Cash Flow: 0
Annual Sales: $0.55
Price / Book: 119.38

Profitability

EPS (TTM): -5.95000
Net Income (TTM): $-1B
Gross Margin: $278M
Return on Equity: -1146.32%
Return on Assets: -57.25%

Insmed Earnings Forecast

Key Insmed Financial Ratios

  • The Gross Profit Margin over the past 26 years for INSM is 76.43%.
  • The Selling, General & Administrative Expenses for INSM have been equal to 126.78% of Gross Profit Margin.
  • The Research & Development expenses have been 164.52% of Revenue.
  • The Net Earning history of INSM is -251.24% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 9 years.

Insmed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INSM
CUSIP: 457669
Website: insmed.com

Debt

Debt-to-Equity Ratio: 11.14
Current Ratio: 5.86
Quick Ratio: 5.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INSM Technical Analysis vs Fundamental Analysis

Sell
41
Insmed (INSM) is a Sell

Is Insmed a Buy or a Sell?

  • Insmed stock is rated a Sell
    The current Insmed [INSM] share price is $65.08. The Score for INSM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.